» Articles » PMID: 22583118

Doctor-patient Communication and Cancer Patients' Choice of Alternative Therapies As Supplement or Alternative to Conventional Care

Overview
Specialty Nursing
Date 2012 May 16
PMID 22583118
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer patients' use of complementary and alternative medicine (CAM) is widespread, despite the fact that clinical studies validating the efficacy of CAM remain sparse in the Nordic countries. The purpose of this study was to explore possible connections between cancer patients' communication experiences with doctors and the decision to use CAM as either supplement or alternative to conventional treatment (CT). The Regional Committee for Medical and Health Research Ethics and the Norwegian Data Inspectorate approved the study. From a group of 52 cancer patients with self-reported positive experiences from use of CAM, 13 were selected for qualitative interviews. Six used CAM as supplement, and seven as alternative to CT, periodically or permanently. Communication experiences with 46 doctors were described. The analysis revealed three connections between doctor-patient communication and patients' treatment decisions: (i) negative communication experiences because of the use of CAM; (ii) negative communication experiences resulted in the decision to use CAM, and in some cases to decline CT; and (iii) positive communication experiences led to the decision to use CAM as supplement, not alternative to CT. The patients, including the decliners of CT, wanted to discuss treatment decisions in well-functioning interpersonal processes with supportive doctors. In doctors' practices and education of doctors, a greater awareness of potential positive and negative outcomes of doctor-patient communication that concern CAM issues could be of importance. More research is needed to safeguard CAM users' treatment decisions and their relationship to conventional health care.

Citing Articles

Exploring primary care physician feedback following an integrative oncology consultation.

Hauzer M, Grimberg R, Samuels N, Keshet Y, Mordechai A, Dagash J Support Care Cancer. 2023; 31(10):606.

PMID: 37787815 DOI: 10.1007/s00520-023-08079-6.


A Qualitative Study Among Healthcare Providers on Risks Associated With the Use of Supportive Care for Cancer Treatment-Related Symptoms in Children and Adolescents.

Mora D, Kristoffersen A, Jong M, Hervik J, Stub T Integr Cancer Ther. 2023; 22:15347354231192959.

PMID: 37551913 PMC: 10411284. DOI: 10.1177/15347354231192959.


Shared decision making: Does a decision aid support patients with an atypical cartilaginous tumor in making a decision about treatment.

Veldman-Goossen P, Deckers C, Dierselhuis E, Schreuder H, van der Geest I PEC Innov. 2023; 1:100086.

PMID: 37213785 PMC: 10194409. DOI: 10.1016/j.pecinn.2022.100086.


Health Communication Research Informs Inflammatory Bowel Disease Practice and Research: A Narrative Review.

Karimi N, Moore A, Lukin A, Connor S Crohns Colitis 360. 2023; 5(3):otad021.

PMID: 37162798 PMC: 10164291. DOI: 10.1093/crocol/otad021.


Clinical associations for traditional and complementary medicine use among norwegian cancer survivors in the seventh survey of the Tromsø study: a cross-sectional study.

Nakandi K, Stub T, Kristoffersen A BMC Complement Med Ther. 2023; 23(1):70.

PMID: 36871025 PMC: 9985214. DOI: 10.1186/s12906-023-03896-y.